Table 1. Pretreatment Characteristics (n=968).
Baseline characteristics of patients who consented to quality of life (QOL) study on RTOG 0828 (using VisionTree Optimal Care, VTOC) and those on the parent study, RTOG 0415 (who did not use VTOC).
| RTOG 0828 QOL (VTOC) Patients (n=49) | RTOG 0415 QOL Patients (No VTOC) (n=919) | p-value* | |
|---|---|---|---|
| Age (years) | 0.005† | ||
| Median | 63 | 67 | |
| Race | 0.906 | ||
| American Indian/Alaska Native | 0 (0.0%) | 6 (0.7%) | |
| Asian | 1 (2.0%) | 11 (1.2%) | |
| African American or Black | 7 (14.3%) | 165 (18.0%) | |
| Native Hawaiian or Other Pacific Islander | 0 (0.0%) | 2 (0.2%) | |
| White | 41 (83.7%) | 726 (79.0%) | |
| Unknown or not reported | 0 (0.0%) | 9 (1%) | |
| Ethnicity | 0.607 | ||
| Hispanic or Latino | 1 (2.0%) | 28 (3.0%) | |
| Not Hispanic or Latino | 46 (93.9%) | 818 (89.0%) | |
| Unknown | 2 (4.1%) | 73 (7.9%) | |
| Zubrod Performance Status | 0.571 | ||
| 0 | 47 (95.9%) | 852 (92.7%) | |
| 1 | 2 (4.1%) | 67 (7.3%) | |
| PSA | 0.714 | ||
| <4 ng/ml | 11 (22.4%) | 183 (19.9%) | |
| 4-<10 ng/ml | 38 (77.6%) | 736 (80.1%) | |
| Gleason | 0.999 | ||
| 2-4 | 0 (0.0%) | 7 (0.8%) | |
| 5-6 | 49 (100.0%) | 912 (99.2%) | |
| Marital Status | 0.366 | ||
| Married or Partnered | 38 (77.6%) | 645 (70.2%) | |
| Other | 10 (20.4%) | 215 (23.4%) | |
| Not Reported | 1 (2.0%) | 59 (6.4%) | |
| Education Level | 0.121 | ||
| Less than High School | 3 (6.1%) | 150 (16.3%) | |
| High School or Some Collage | 27 (55.1%) | 405 (44.1%) | |
| Bachelor's and/or Above | 15 (30.6%) | 238 (25.9%) | |
| Other, Not Reported | 4 (8.2%) | 126 (13.7%) |
*
Age based on Wilcoxon test; all other variables based on exact chi-square test; race and ethnicity were defined by the patients
†
Significant at the 0.05 level (two-sided p value)